Astellas Pharma | 4503 - Sales Revenues

Stock Price
2,291.50
Daily Change
-33.00 -1.42%
Monthly
-10.84%
Yearly
66.72%
Q2 Forecast
2,231.98

Astellas Pharma reported JPY537.93B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Astellas Pharma JPY 537.93B 33.28B Mar/2026
Chugai Pharma JPY 321.75B 24.55B Mar/2026
Daiichi Sankyo JPY 587B 28.89B Mar/2026
Eisai JPY 219.94B 22.58B Dec/2025
Kyowa Hakko Kirin JPY 118.47B 28.91B Mar/2026
M3 JPY 86.97B 6.54B Mar/2026
Otsuka Holdings JPY 630.34B 19.81B Mar/2026
Shionogi JPY 138.99B 8.73B Mar/2026
Sumitomo Dainippon JPY 105.55B 15.07B Mar/2026
Takeda JPY 1.09T 100B Mar/2026
Terumo JPY 296.63B 21.66B Dec/2025